Differential regulation of insulin resistance and hypertension by sex hormones in fructose-fed male rats.

Faculty of Pharmaceutical Sciences, University of British Columbia, 2146 East Mall, Vancouver, BC, V6T 1Z3, Canada.
AJP Heart and Circulatory Physiology (Impact Factor: 4.01). 11/2005; 289(4):H1335-42. DOI: 10.1152/ajpheart.00399.2005
Source: PubMed

ABSTRACT Differences in gender are in part responsible for the development of insulin resistance (IR) and associated hypertension. Currently, it is unclear whether these differences are dictated by gender itself or by the relative changes in plasma estrogen and/or testosterone. We investigated the interrelationships between testosterone and estrogen in the progression of IR and hypertension in vivo in intact and gonadectomized fructose-fed male rats. Treatment with estrogen significantly reduced the testosterone levels in both normal chow-fed and fructose-fed rats. Interestingly, fructose feeding induced a relative increase in estradiol levels, which did not affect IR in both intact and gonadectomized fructose-fed rats. However, increasing the estrogen levels improved insulin sensitivity in both intact and gonadectomized fructose-fed rats. In intact males, fructose feeding increased the blood pressure (140 +/- 2 mmHg), which was prevented by estrogen treatment. However, the blood pressure in the fructose-fed estrogen rats (125 +/- 1 mmHg) was significantly higher than that of normal chow-fed (113 +/- 1 mmHg) and fructose-fed gonadectomized rats. Estrogen treatment did not affect the blood pressure in gonadectomized fructose-fed rats (105 +/- 2 mmHg). These data suggest the existence of a threshold value for estrogen below which insulin sensitivity is unaffected. The development of hypertension in this model is dictated solely by the presence or absence of testosterone. In summary, the development of IR and hypertension is governed not by gender per se but by the interactions of specific sex hormones such as estrogen and testosterone.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Selected steroid compounds (androsterone, epi‐androsterone, dehydro‐epi‐androsterone, testosterone, stigmasterol, β‐sitosterol, estradiol, hydrocortisone, and cholesterol) were separated by adsorption TLC on silica gel 60, not activated, and activated at temperatures of 100°C, 120°C, 150°C, and 200°C, during 15, 30, 60, and 120 min, respectively. The mixture of chloroform and acetone (85∶15, v/v) was used as mobile phase. The lowest RF values of particular substances investigated were obtained on chromatographic plates precoated by silica gel activated at a temperature of 120°C. The time and activation temperature of silica gel influenced the order of substances adsorbed, the values of separation factors: ΔRF, RF and α. None of the chromatographic conditions used allowed for the separation of the following pairs of substances: androsterone‐dehydro‐epi‐androsterone, and testosterone‐estradiol.
    Journal of Liquid Chromatography &amp Related Technologies 08/2006; 29(14):2035-2044. · 0.64 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Hyperandrogenism and vascular dysfunction often coexist in women with Polycystic Ovary Syndrome (PCOS). We hypothesized that testosterone compromises cutaneous microvascular dilation in women with PCOS via the endothelin-1 ET-B subtype receptor. To control and isolate testosterone effects on microvascular dilation, we administered a gonadotropin releasing hormone antagonist (GnRHant) for 11 days in obese otherwise healthy women [(Controls, 22.0 (4) y, 36.0 (3.2) kg/m(2))] or women with PCOS [23 (4) y, 35.4 (1.3) kg/m2)], adding testosterone (T, 2.5 mg/day) for days 8-11. Using laser Doppler flowmetry and cutaneous microdialysis, we measured changes in skin microcirculatory responsiveness (ΔCVC) to local heating while perfusing ET-A (BQ-123) and ET-B (BQ-788) receptor antagonists under three experimental conditions: baseline (BL, pre-hormone intervention), GnRHant (day 4 of administration), and T administration. At BL, ET-A receptor inhibition enhanced heat-induced vasodilation in both groups [ΔCVC Control 2.03 (0.65), PCOS 2.10 (0.25), AU/mmHg, P< 0.05]; ET-B receptor inhibition reduced vasodilation in Controls only [ΔCVC 0.98 (0.39), 1.41 (0.45) AU/mmHg for Controls, PCOS] compared to saline [ΔCVC Controls 1.27 (0.48), PCOS 1.31 (0.13) AU/mmHg]. GnRHant enhanced vasodilation in PCOS [saline ΔCVC 1.69 (0.23) AU/mmHg vs. BL, P<0.05), and abolished the ET-A effect in both groups; a response reasserted with T in Controls. ET-B receptor inhibition reduced heat-induced vasodilation in both groups during GnRHant and T [ΔCVC, Controls: 0.95 (0.21) vs. 0.51 (13), PCOS: 1.27 (0.23) vs. 0.84 (0.27); for GnRHant vs. T, P< 0.05)]. These data demonstrate androgen suppression improves microvascular dilation in PCOS via ET-A and ET-B receptors.
    AJP Endocrinology and Metabolism 08/2013; · 4.51 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Combinations of fructose-and fat-rich diets in experimental animals can model the human metabolic syndrome (MS). In rats, the increase in blood pressure (BP) after diet manipulation is sex related and highly dependent on testosterone secretion. However, the extent of the impact of diet on rodent hypophysial-testicular axis remains undefined. In the present study, rats drink-ing a 10% fructose solution or fed a high-fat (35%) diet for 10weeks had higher plasma levels of luteinizing hormone (LH) and lower plasma levels of testosterone, without significant changes in circulating follicle-stimulating hormone or the weight of most reproductive organs. Diet manipulation brought about a significant increase in body weight, systolic BP, area under the curve (AUC) of glycemia after an intraperitoneal glucose tolerance test (IPGTT), and plasma low-density lipoprotein cholesterol, cholesterol, triglycerides, and uric acid levels. The con-comitant administration of melatonin (25 μg/mL of drink-ing water) normalized the abnormally high LH levels but did not affect the inhibited testosterone secretion found in fructose-or high-fat-fed rats. Rather, melatonin per se inhibited testosterone secretion. Melatonin significantly blunted the body weight and systolic BP increase, the increase in the AUC of glycemia after an IPGTT, and the changes in circulating lipid profile and uric acid found in both MS models. The results are compatible with a pri-mary inhibition of testicular function in diet-induced MS in rats and with the partial effectiveness of melatonin to counteract the metabolic but not the testicular sequelae of rodent MS.
    Hormone molecular biology and clinical investigation 07/2013; 16(2):101-112.

Full-text (2 Sources)

Available from
Jun 1, 2014